Dr. Marwan Sabbagh On AAIC 2024: It’s “Heads Down. Now, Let’s Get to Work”
At AAIC, the Alzheimer’s Association’s International Conference, the world’s leading scientists, researchers, and clinicians gather to discuss the latest discoveries and upcoming research in brain health research. Last year, much of the conversation revolved around monoclonal antibody drugs, many of which were not on the market yet. With lecanamab (Leqembi) and donanemab (Kisunla) now available, what’s the focus for clinicians and researchers this year?
This week, at the 2024 conference in downtown Philadelphia, Being Patient founder Deborah Kan has been connecting with leaders of the field all week to find out that focus, including neurologist and Alzheimer’s expert Dr. Marwan Sabbagh.
---
If you loved watching this quick Live Talk, visit our website to find more of our Alzheimer’s coverage and subscribe to our newsletter: https://www.beingpatient.com/
Follow Being Patient:
Twitter: / being_patient_
Instagram: / beingpatientvoices
Facebook: / beingpatientalzheimers
LinkedIn: / being-patient
Being Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia.
Check out our latest Live Talks: https://www.beingpatient.com/category...